Baret News – Lifestyle
Author:
Bragar Eagel & Squire
Bragar Eagel & Squire, P.C. Reminds Aquestive Therapeutics, Inc. Investors with Significant Losses to Contact the Firm Before Upcoming Lead Plaintiff Deadline
March 30, 2026
XPONENTIAL INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Xponential Fitness, Inc. on Behalf of Xponential Stockholders and Encourages Investors to Contact the Firm
March 30, 2026
VITAL FARMS LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Vital Farms, Inc. and Encourages Investors to Contact the Firm
March 30, 2026
IMMUNITYBIO CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against ImmunityBio, Inc. and Encourages Investors to Contact the Firm
March 30, 2026
Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Atara Biotherapeutics, Inc. (NASDAQ:ATRA) and Encourages Investors to Contact the Firm
March 27, 2026
COTY INVESTOR ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Coty, Inc. and Encourages Investors to Contact the Firm
March 27, 2026
ADMA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating ADMA Biologics, Inc. on Behalf of ADMA Stockholders and Encourages Investors to Contact the Firm
March 27, 2026
NEKTAR CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Nektar Therapeutics and Encourages Investors to Contact the Firm
March 27, 2026
CONCORDE LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Concorde International Group Ltd. and Encourages Investors to Contact the Firm Regarding Their Rights
March 26, 2026
SUPER MICRO LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Super Micro Computer, Inc. and Encourages Investors to Contact the Firm
March 26, 2026
←
Previous Page
1
…
9
10
11
12
13
…
18
Next Page
→